Literature DB >> 11807462

Colchicine and indomethacin for the treatment of relapsing polychondritis.

Kenneth A Mark1, Andrew G Franks.   

Abstract

This report describes the effectiveness of oral colchicine and indomethacin in the maintenance phase of treatment of relapsing polychondritis. Systemic corticosteroids are commonly used in the induction phase of managing cases of relapsing polychondritis. Clinicians are then faced with the challenge of controlling the patient's symptoms while trying to decrease the dose of steroid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807462     DOI: 10.1067/mjd.2002.105477

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

Review 2.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

Review 3.  Colchicine: an ancient drug with novel applications.

Authors:  B Dasgeb; D Kornreich; K McGuinn; L Okon; I Brownell; D L Sackett
Journal:  Br J Dermatol       Date:  2018-01-03       Impact factor: 9.302

4.  [A case report of colchicine-induced myopathy in a patient with chronic kidney disease].

Authors:  Y J DU; W C Liu; X Chen; Y J Cheng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

Review 5.  Relapsing Polychondritis: An Updated Review.

Authors:  Francesco Borgia; Roberta Giuffrida; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-08-02

6.  An undiagnosed patient with skin rash, polyarthritis, and edema responding to low-dose colchicine: A case report.

Authors:  Hiroki Maita; Tadashi Kobayashi; Takashi Akimoto; Hiroshi Osawa; Keisuke Hasui; Hiroyuki Kato
Journal:  SAGE Open Med Case Rep       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.